|
TM9SF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.25569999953612E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.49499998439262E-09 |
| Normal-vs-Stage2 |
3.797000E-03 |
| Normal-vs-Stage3 |
6.155900E-03 |
| Normal-vs-Stage4 |
3.677800E-01 |
| Stage1-vs-Stage2 |
6.688000E-01 |
| Stage1-vs-Stage3 |
4.006600E-01 |
| Stage1-vs-Stage4 |
1.942000E-01 |
| Stage2-vs-Stage3 |
7.993000E-01 |
| Stage2-vs-Stage4 |
4.356800E-01 |
| Stage3-vs-Stage4 |
5.491400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.80999995178655E-09 |
| Normal-vs-AfricanAmerican |
7.88600000000139E-05 |
| Normal-vs-Asian |
8.930100E-02 |
| Caucasian-vs-AfricanAmerican |
5.199200E-01 |
| Caucasian-vs-Asian |
8.978600E-01 |
| AfricanAmerican-vs-Asian |
7.167800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.07690547987727E-11 |
| Normal-vs-Female |
1.386370E-01 |
| Male-vs-Female |
1.017210E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.1085999999968E-05 |
| Normal-vs-Extreme_Weight |
3.82709974822149E-10 |
| Normal-vs-Obese |
4.219000E-04 |
| Normal-vs-Extreme_Obese |
2.399900E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.130600E-01 |
| Normal_Weight-vs-Obese |
3.593400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.947200E-01 |
| Extreme_Weight-vs-Obese |
2.780200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.322200E-01 |
| Obese-vs-Extreme_Obese |
1.666440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.027400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.11710000000065E-05 |
| Normal-vs-Age(61-80Yrs) |
1.72220016025904E-10 |
| Normal-vs-Age(81-100Yrs) |
7.77890000192016E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.774840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.721600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.539980E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.497540E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.626000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.732400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.80519995910345E-09 |
| Normal-VS-Type2 PRCC |
3.02190494849697E-11 |
| Normal-VS-KIRP CIMP |
1.403970E-01 |
| Normal-VS-Unclassified PRCC |
1.272370E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.158000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.50870000001657E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
2.140600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.940800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.011900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.999100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.16349979335007E-10 |
| Normal-vs-N1 |
3.451200E-01 |
| Normal-vs-N2 |
9.215200E-01 |
| N0-vs-N1 |
1.012010E-02 |
| N0-vs-N2 |
2.544400E-01 |
| N1-vs-N2 |
6.249400E-01 |
|
|
